JOYCE VILLASENOR ROCHA: Open Payments
NPI 1083272405 · MCALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,241 in 61 payments from 26 companies in 2025. Trend: 2023 $723 · 2024 $311 · 2025 $1,241
Food & beverage: $1,063Education: $178
| Company | Payments | Amount |
|---|---|---|
| Celgene Corporation | 12 | $162 |
| Daiichi Sankyo Inc. | 9 | $146 |
| Incyte Corporation | 1 | $100 |
| Merck Sharp & Dohme LLC | 4 | $85 |
| SEAGEN INC. | 1 | $78 |
| Genentech USA, Inc. | 3 | $71 |
| E.R. Squibb & Sons, L.L.C. | 3 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $60 |
| PFIZER INC. | 5 | $52 |
| Karyopharm Therapeutics Inc. | 2 | $39 |
Products named: Enhertu, REBLOZYL, KEYTRUDA, OPDUALAG, Tecentriq, XPOVIO, LONSURF, IBRANCE.
Industry payments across TX — which companies pay providers there.
